Lineage Cell Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 67.2% | -1,133.6% | -991.0% |
| FY2022 | 95.0% | -153.2% | -178.7% |
| FY2023 | 92.5% | -276.5% | -240.2% |
| FY2024 | 96.5% | -226.1% | -195.9% |
| FY2025 | — | -251.6% | -436.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 67.2% | -1,133.6% | -991.0% |
| FY2022 | 95.0% | -153.2% | -178.7% |
| FY2023 | 92.5% | -276.5% | -240.2% |
| FY2024 | 96.5% | -226.1% | -195.9% |
| FY2025 | — | -251.6% | -436.5% |